Novel approach could aid selective breeding in cattle
Researchers aim to pinpoint non-gene components in DNA linked to production and welfare traits in cattle, gaining insights across species.
SuRE technology finds hidden gene regulation
Many diseases are determined by differences in yet undiscovered gene regulation. Thanks to plasmids and ‘barcodes’, the SuRE assay can map this for the entire human genome.
Annogen BV, a precision medicine company for the non-coding genome, signs research agreement with top tier pharma company.
Annogen will use its proprietary SuRE™ technology to generate genome-wide regulatory profiles to identify disease-relevant regulatory activity and non-coding sequence variants.
Collaboration agreement with a Tier 1 agricultural firm to research non-coding regulatory DNA.
Annogen started a collaboration with a Tier 1 agri firm to test non-coding DNA fragments predicted to influence the expression of important crop traits.
Annogen signs collaboration agreement with Tier 1 agricultural firm to research non-coding DNA influencing gene expression using SuRE™ screening technology
Annogen started a collaboration with a Tier 1 agricultural firm to identify non-coding DNA fragments in plants’ genomes that influence the expression of important crop traits.
Annogen and KeyGene to collaborate in research on non-coding DNA influencing gene expression
Annogen and KeyGene are to collaborate in identifying non-coding DNA fragments in plants’ genomes that influence the expression of important crop traits.
Annogen incorporated to commercialize SuRE technology for Functional Genome Annotation.
Annogen BV was incorporated with exclusive rights to commercialize the SuRE technology outside the gene therapy field, for drug discovery, pharmacogenomics, cell therapy and agricultural biotechnology.
